Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

11.23
Delayed Data
As of Jul 01
 +0.71 / +6.75%
Today’s Change
8.90
Today|||52-Week Range
30.23
-28.61%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close10.52
Today’s open10.50
Day’s range10.36 - 11.26
Volume334,186
Average volume (3 months)418,177
Market cap$411.7M
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+12.14%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.05-2.92%
ENTAEnanta Pharmaceutica...+0.56+2.54%
RETAReata Pharmaceutical...+0.24+1.22%
ACRSAclaris Therapeutics...+0.58+3.14%
Data as of 4:00pm ET, 07/01/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers

Search for Jobs